İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

BİLGE ÇİFTCİ

ÖĞRETİM GÖREVLİSİ (DERS VERMEKLE GÖREVLİ)

BİLECİK ŞEYH EDEBALİ ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 19
  • Proje 0
  • Kitap 0
  • Bildiri 2
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 9 Q2 8 Q3 0 Q4 0
WoS (JCR) Q1 0 Q2 17 Q3 0 Q4 0
TR Index 2 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 9
Ort. yüzdelik 79.0%
Üst %1 payı 0.0%
Üst %10 payı 47.4%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 19 yayın

Scopus (SJR)
Q1 9 Q2 8 Q3 0 Q4 0
WoS (JCR)
Q1 0 Q2 17 Q3 0 Q4 0
TR Index
2 makale

Makale listesi

  1. 2026 Benzothiazole-thiadiazole hybrids as dual α-glucosidase and aldose reductase inhibitors: Synthesis, in vitro, and In Silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144995 YÖKSİS SJR Q2 JCR Q2 OpenAlex 28.2%
  2. 2026 Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents Molecules DOI 10.3390/molecules31152635 YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.8%
  3. 2026 Benzothiazole-thiadiazole hybrids as dual α-glucosidase and aldose reductase inhibitors: Synthesis, in vitro, and In Silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144995 YÖKSİS SJR Q2 JCR Q2 OpenAlex 28.2%
  4. 2026 Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents Molecules DOI 10.3390/molecules31152635 YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.8%
  5. 2025 Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies Drug Development Research DOI 10.1002/ddr.70060 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.4%
  6. 2025 Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus ACS Omega DOI 10.1021/acsomega.5c00566 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.0%
  7. 2025 Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease ACS Omega DOI 10.1021/acsomega.5c01055 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.6%
  8. 2025 Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus ACS Omega DOI 10.1021/acsomega.5c00566 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.0%
  9. 2025 Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy ChemistryOpen DOI 10.1002/open.202500305 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.9%
  10. 2025 Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease ACS Omega DOI 10.1021/acsomega.5c01055 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.6%
  11. 2024 Synthesis, α-Glucosidase, α-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2-a]pyridine Derivatives ACS Omega DOI 10.1021/acsomega.4c05619 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 97.6%
  12. 2024 Design, Synthesis and Cholinesterase Inhibitory Activity of Novel 1,3,4-Thiadiazole Derivatives Cumhuriyet Science Journal DOI 10.17776/csj.1449622 YÖKSİS TR Index OpenAlex 75.5%
  13. 2024 Functionalized methoxy quinoline derivatives: Experimental and in silico evaluation as new antiepileptic, anti-Alzheimer, antibacterial and antifungal drug candidates European Journal of Medicinal Chemistry Reports DOI 10.1016/j.ejmcr.2023.100127 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.1%
  14. 2024 Synthesis, α-Glucosidase, α-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2-a]pyridine Derivatives ACS Omega DOI 10.1021/acsomega.4c05619 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 97.6%
  15. 2026 Benzothiazole-thiadiazole hybrids as dual α-glucosidase and aldose reductase inhibitors: Synthesis, in vitro, and In Silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144995 YÖKSİS SJR Q2 JCR Q2 OpenAlex 28.2%
  16. 2025 Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies Drug Development Research DOI 10.1002/ddr.70060 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.4%
  17. 2025 Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy ChemistryOpen DOI 10.1002/open.202500305 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.7%
  18. 2025 Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus ACS Omega DOI 10.1021/acsomega.5c00566 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.9%
  19. 2024 Design, Synthesis and Cholinesterase Inhibitory Activity of Novel 1,3,4-Thiadiazole Derivatives Cumhuriyet Science Journal DOI 10.17776/csj.1449622 YÖKSİS TR Index OpenAlex 75.4%

Akademisyenlere dön